Certification of competitive sports participation of a professional soccer player with hypertrophic cardiomyopathy and implanted ICD

[1] Meinertz T(2015)German Heart Report 2013 Clin Res Cardiol 104 112-123

[2] Diegeler A(2006)Guidelines for the implantation of defibrillators Clin Res Cardiol 95 696-708

[3] Stiller B(2005)Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology Eur Heart J 26 1422-1445

[4] Fleck E(2013)Safety of sports for athletes with implantable cardioverter-defibrillators: results of a prospective, multinational registry Circulation 127 2021-2030

[5] Heinemann MK(2006)Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis Eur J Cardiovasc Prev Rehabil 13 876-885

[6] Schmaltz AA(2015)Eligibility and Disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology J Am Coll Cardiol 66 2362-2371

[7] Vestweber M(2009)“Home monitoring” for early detection of implantable cardioverter-defibrillator failure: a single-center prospective observational study Clin Res Cardiol 98 19-24

[8] Bestehorn K(2014)2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) Eur Heart J 35 2733-2779

[9] Beckmann A(2015)Long-term follow-up of subcutaneous ICD systems in patients with hypertrophic cardiomyopathy: a single-center experience Clin Res Cardiol 98 116-125

[10] Hamm C(2012)The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy Heart (British Cardiac Society) 100 383-394

[1] Meinertz T(2015)German Heart Report 2013 Clin Res Cardiol 104 112-123

[2] Diegeler A(2006)Guidelines for the implantation of defibrillators Clin Res Cardiol 95 696-708

[3] Stiller B(2005)Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology Eur Heart J 26 1422-1445

[4] Fleck E(2013)Safety of sports for athletes with implantable cardioverter-defibrillators: results of a prospective, multinational registry Circulation 127 2021-2030

[5] Heinemann MK(2006)Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis Eur J Cardiovasc Prev Rehabil 13 876-885

[6] Schmaltz AA(2015)Eligibility and Disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology J Am Coll Cardiol 66 2362-2371

[7] Vestweber M(2009)“Home monitoring” for early detection of implantable cardioverter-defibrillator failure: a single-center prospective observational study Clin Res Cardiol 98 19-24

[8] Bestehorn K(2014)2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) Eur Heart J 35 2733-2779

[9] Beckmann A(2015)Long-term follow-up of subcutaneous ICD systems in patients with hypertrophic cardiomyopathy: a single-center experience Clin Res Cardiol 98 116-125

[10] Hamm C(2012)The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy Heart (British Cardiac Society) 100 383-394